TG Therapeutics TGTX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $442.21M+459% | $79.15M+6.8% | $74.08M-42.6% | $129.13M-2.3% | $132.14M-26.5% | ||
| $392.05M+28.3% | $305.63M+15.2% | $265.38M+14.6% | $231.52M+21.8% | $190.12M+47.2% | ||
| $26.35M+67.9% | $15.69M-89.3% | $146.95M-5.3% | $155.2M-1.6% | $157.76M— | ||
| $1.09B+72.3% | $630.76M+5.2% | $599.77M-9.7% | $663.96M+3.0% | $644.51M+13.8% | ||
| $72.22M+15.0% | $62.82M+9.3% | $57.5M-53.2% | $122.74M-14.8% | $144.1M+9.9% | ||
| $1.53B+43.8% | $1.06B+3.7% | $1.03B+45.9% | $702.61M+7.0% | $656.69M+13.7% | ||
| $148.85M+38.5% | $107.51M-4.3% | $112.34M-16.2% | $134.02M+0.1% | $133.93M+130% | ||
| $6.86M-22.1% | $8.81M+5.5% | $8.35M+401% | $1.67M-74.7% | $6.6M-45.4% | ||
| $187.11M+21.7% | $153.76M-1.9% | $156.81M-8.8% | $171.89M+7.3% | $160.21M+76.7% | ||
| $745.14M+203% | $245.65M+0.1% | $245.34M+0.1% | $245.04M+0.1% | $244.73M+0.1% | ||
| $945.71M+128% | $415.23M-0.6% | $417.81M-2.0% | $426.18M+1.6% | $419.4M+18.0% | ||
| $160K+0.6% | $159K0.0% | $159K0.0% | $159K0.0% | $159K+1.9% | ||
| -$1.06B+1.8% | -$1.08B+2.1% | -$1.11B+26.1% | -$1.5B+1.8% | -$1.52B+0.3% | ||
| $583.13M-10.0% | $648.02M+6.7% | $607.22M+120% | $276.43M+16.5% | $237.29M+6.7% | ||
| $1.53B+43.8% | $1.06B+3.7% | $1.03B+45.9% | $702.61M+7.0% | $656.69M+13.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TG Therapeutics's total assets?
- TG Therapeutics (TGTX) holds $1.5B in total assets, up 132.8% year over year.
- How much debt does TG Therapeutics have?
- TG Therapeutics carries $753.6M in total debt against $583.1M of shareholders' equity, a debt-to-equity ratio of 1.29.
- How much cash does TG Therapeutics have?
- TG Therapeutics holds $442.2M in cash and equivalents.
- Can TG Therapeutics cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does TG Therapeutics's balance sheet data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
